Diabetes drugs may melt heart fat, study shows
NCT ID NCT03498001
First seen Feb 04, 2026 · Last updated May 16, 2026 · Updated 13 times
Summary
This study looked at whether GLP-1 agonist drugs (like liraglutide) can reduce fat buildup in the hearts of people with type 2 diabetes. 42 adults over 50 with diabetes and at least one heart risk factor were enrolled. Researchers used MRI scans to measure heart fat before and after 6 months of treatment. The goal was to understand how these drugs protect the heart, independent of blood sugar control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE II DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu Dijon Bourgogne
Dijon, 21000, France
Conditions
Explore the condition pages connected to this study.